Efficacy and safety of escitalopram in the treatment of depressive patients with acute coronary artery syndrome: a double-blind placebo-controlled trial.

Trial Profile

Efficacy and safety of escitalopram in the treatment of depressive patients with acute coronary artery syndrome: a double-blind placebo-controlled trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register KCT0000053)
    • 25 Aug 2011 Planned number of patients is 300 as reported by Korean Clinical Trials Register.
    • 06 Jul 2011 Planned end date changed from 1 Dec 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top